View Filing Data

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2020	May 01, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Entity Registrant Name	Benefitfocus,Inc.
Entity Central Index Key	0001576169
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		32,063,446
Title of 12(b) Security	Common Stock, $0.001 Par Value
Trading Symbol	BNFT
Entity Incorporation, State or Country Code	DE
Security Exchange Name	NASDAQ
Entity File Number	001-36061
Entity Tax Identification Number	46-2346314
Entity Address, Address Line One	100 Benefitfocus Way
Entity Address, City or Town	Charleston
Entity Address, State or Province	SC
Entity Address, Postal Zip Code	29492
City Area Code	843
Local Phone Number	849-7476
Document Quarterly Report	true
Document Transition Report	false

Unaudited Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 114,714	$ 130,976
Accounts receivable, net	33,450	33,754
Contract, prepaid and other current assets	21,271	21,523
Total current assets	169,435	186,253
Property and equipment, net	31,507	28,669
Financing lease right-of-use assets	75,687	78,520
Operating lease right-of-use assets	1,591	1,715
Intangible assets, net	12,099	12,667
Goodwill	12,857	12,857
Deferred contract costs and other non-current assets	10,445	11,002
Total assets	313,621	331,683
Current liabilities:
Accounts payable	6,300	9,563
Accrued expenses	11,937	10,526
Accrued compensation and benefits	11,245	15,246
Deferred revenue, current portion	29,736	33,429
Lease liabilities and financing obligations, current portion	8,240	6,871
Total current liabilities	67,458	75,635
Deferred revenue, net of current portion	4,803	5,079
Convertible senior notes	190,873	187,949
Revolving line of credit	10,000	0
Lease liabilities and financing obligations, net current portion	82,891	88,572
Other non-current liabilities	68	92
Total liabilities	356,093	357,327
Commitments and contingencies	0	0
Stockholders' deficit:
Preferred stock, par value $0.001, 5,000,000 shares authorized, no shares issued and outstanding at March 31, 2020 and December 31, 2019	0	0
Common stock, par value $0.001, 50,000,000 shares authorized, 31,778,075 and 32,788,980 shares issued and 31,775,214 and 32,788,980 shares outstanding at March 31, 2020 and December 31, 2019, respectively	32	33
Additional paid-in capital	420,393	426,025
Accumulated deficit	(462,897)	(451,702)
Total stockholders' deficit	(42,472)	(25,644)
Total liabilities and stockholders' deficit	$ 313,621	$ 331,683

Unaudited Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	31,778,075	32,788,980
Common stock, shares outstanding	31,775,214	32,788,980

Unaudited Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenue	$ 66,154	$ 68,299
Cost of revenue	33,912	32,852
Gross profit	32,242	35,447
Operating expenses:
Sales and marketing	15,630	19,619
Research and development	11,768	13,090
General and administrative	10,515	11,796
Total operating expenses	37,913	44,505
Loss from operations	(5,671)	(9,058)
Other income (expense):
Interest income	426	660
Interest expense	(5,891)	(5,814)
Other income	5	9
Total other expense, net	(5,460)	(5,145)
Loss before income taxes	(11,131)	(14,203)
Income tax expense	5	6
Net loss	(11,136)	(14,209)
Comprehensive loss	$ (11,136)	$ (14,209)
Net loss per common share:
Basic and diluted	$ (0.34)	$ (0.44)
Weighted-average common shares outstanding:
Basic and diluted	32,638,805	32,056,934

Unaudited Consolidated Statements of Changes in Stockholders' Deficit - USD ($) $ in Thousands	Total	Common Stock, $0.001 Par Value	Additional Paid-in Capital	Accumulated Deficit
Balance at Dec. 31, 2018	$ (10,210)	$ 32	$ 403,631	$ (413,873)
Balance (in shares) at Dec. 31, 2018		32,017,773
Cumulative effect adjustment from adoption of credit standard (Accounting Standards Update ("ASU") 2016-02) at Dec. 31, 2018	7,687	$ 0	0	7,687
Exercise of stock options	89	$ 0	89	0
Exercise of stock options (in shares)		18,600
Issuance of common stock upon vesting of restricted stock units	0	$ 0	0	0
Issuance of common stock upon vesting of restricted stock units (in shares)		34,255
Stock-based compensation expense	6,253	$ 0	6,253	0
Net loss	(14,209)	0	0	(14,209)
Balance at Mar. 31, 2019	(10,390)	$ 32	409,973	(420,395)
Balance (in shares) at Mar. 31, 2019		32,070,628
Balance at Dec. 31, 2019	$ (25,644)	$ 33	426,025	(451,702)
Balance (in shares) at Dec. 31, 2019	32,788,980	32,788,980
Cumulative effect adjustment from adoption of credit standard (Accounting Standards Update ("ASU") 2016-02) at Dec. 31, 2019	$ (59)	$ 0	0	(59)
Exercise of stock options	73	$ 0	73	0
Exercise of stock options (in shares)		13,584
Issuance of common stock upon vesting of restricted stock units	0	$ 0	0	0
Issuance of common stock upon vesting of restricted stock units (in shares)		43,315
Stock-based compensation expense	3,677	$ 0	3,677	0
Common stock repurchased	(9,383)	$ (1)	(9,382)	0
Common stock repurchased (in shares)		(1,070,665)
Net loss	(11,136)	$ 0	0	(11,136)
Balance at Mar. 31, 2020	$ (42,472)	$ 32	$ 420,393	$ (462,897)
Balance (in shares) at Mar. 31, 2020	31,775,214	31,775,214

Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities
Net loss	$ (11,136)	$ (14,209)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Depreciation and amortization	5,884	5,335
Stock-based compensation expense	3,677	6,367
Accretion of interest on convertible senior notes	2,924	2,749
Interest accrual on finance lease liabilities	23	0
Rent expense (less than) in excess of payments	(9)	9
Provision for doubtful accounts	55	265
Changes in operating assets and liabilities:
Accounts receivable, net	189	(6,514)
Contract, prepaid and other current assets	252	(2,495)
Deferred costs and other non-current assets	557	1,568
Accounts payable and accrued expenses	(1,593)	(4,867)
Accrued compensation and benefits	(4,000)	(3,580)
Deferred revenue	(3,969)	(5,089)
Other non-current liabilities	(24)	(23)
Net cash and cash equivalents used in operating activities	(7,170)	(20,484)
Cash flows from investing activities
Business combination, net of cash acquired	0	(21,033)
Purchases of property and equipment	(3,821)	(2,955)
Net cash and cash equivalents used in investing activities	(3,821)	(23,988)
Cash flows from financing activities
Draws on revolving line of credit	10,000	0
Payments of debt issuance costs	(154)	(357)
Repurchase of common stock	(9,383)	0
Proceeds from exercises of stock options and ESPP	73	89
Payments on financing obligations	(207)	(655)
Payments of principal on finance lease liabilities	(5,600)	(1,375)
Net cash and cash equivalents used in financing activities	(5,271)	(2,298)
Net decrease in cash and cash equivalents	(16,262)	(46,770)
Cash and cash equivalents, beginning of period	130,976	190,928
Cash and cash equivalents, end of period	114,714	144,158
Supplemental disclosure of non-cash investing and financing activities
Property and equipment purchases in accounts payable and accrued expenses	$ 31	$ 382

Organization and Description of Business

3 Months Ended

Mar. 31, 2020

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Organization and Description of Business

1. Organization and Description of Business

Benefitfocus, Inc. (the “Company”) provides a leading cloud-based benefits management platform for consumers, employers, insurance carriers and brokers that is designed to simplify how organizations and individuals transact benefits. The financial statements of the Company include the financial position and operations of its wholly owned subsidiaries, Benefitfocus.com, Inc. and BenefitStore, Inc.

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Principles of Consolidation

These consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company is not the primary beneficiary of, nor does it have a controlling financial interest in, any variable interest entity. Accordingly, the Company has not consolidated any variable interest entity.

Interim Unaudited Consolidated Financial Information

The accompanying unaudited consolidated financial statements and footnotes have been prepared in accordance with GAAP as contained in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (the “Codification” or “ASC”) for interim financial information, and with Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the interim financial information includes all adjustments of a normal recurring nature necessary for a fair presentation of the results of operations, financial position, changes in stockholders’ deficit and cash flows. The results of operations for the three-month period ended March 31, 2020 are not necessarily indicative of the results for the full year or for any other future period. These unaudited consolidated financial statements should be read in conjunction with the audited financial statements and related footnotes for the year ended December 31, 2019 included in the Company’s Annual Report on Form 10-K.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Such estimates include allowances for doubtful accounts and returns, valuations of deferred income taxes, long-lived assets, capitalizable software development costs and the related amortization, incremental borrowing rate used in lease accounting, the determination of the useful lives of assets, and the impairment assessment of acquired intangibles and goodwill as well as the estimates disclosed in association with revenue recognition. Determination of these transactions and account balances are based on, among other things, the Company’s estimates and judgments. These estimates are based on the Company’s knowledge of current events and actions it may undertake in the future as well as on various other assumptions that it believes to be reasonable. Actual results could differ materially from these estimates.

Revenue and Deferred Revenue

The Company derives its revenue primarily from fees for subscription services and professional services sold to employers and insurance carriers as well as platform revenue derived from the value of products sold on our platform. Revenue is recognized when control of these services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. Taxes collected from customers relating to services and remitted to governmental authorities are excluded from revenue.

The Company determines revenue recognition through the following steps:

•

Identification of each contract with a customer;

•

Identification of the performance obligations in the contract;

•

Determination of the transaction price;

•

Allocation of the transaction price to the performance obligations in the contract; and

•

Recognition of revenue when, or as, performance obligations are satisfied.

Software Services Revenue

Software services revenue consists of subscription revenue and platform revenue.

Subscription Revenue

Subscription revenue primarily consists of monthly subscription fees paid to the Company by its employer and insurance carrier customers for access to, and usage of, cloud-based benefits software solutions for a specified contract term. Fees are generally charged based on the number of employees or subscribers with access to the solution.

Subscription services revenue is generally recognized on a ratable basis over the contract term beginning on the date the subscription services are made available to the customer. The Company’s subscription service contracts are generally three years.

Subscription revenue also includes fees paid for other services, such as event sponsorships and certain data services.

Platform Revenue

Platform revenue is generated from the value of policies or products enrolled in through the Company’s marketplace. Platform revenue from carriers is generally recognized over the policy period of the enrolled products. In arrangements where the Company sells policies to employees of its customers as the broker, it earns broker commissions. Revenue from insurance broker commissions and supplier transactions is recognized at a point in time when the orders for the policies are received and transferred to the insurance carrier or supplier, and is reduced by estimates for risks from collectability, policy cancellation and termination.

Professional Services Revenue

Professional services revenue primarily consists of fees related to the implementation of software products purchased by customers. Professional services typically include discovery, configuration and deployment, integration, testing, and training. Fees from consulting services and support services are also included in professional services revenue.

The Company determined that implementation services for certain of its insurance carrier customers significantly modify or customize the software solution and, as such, do not represent a distinct performance obligation. Accordingly, revenue from such implementation services with these insurance carrier customers are generally recognized over the contract term of the associated subscription services contract, including any extension periods representing a material right. In certain arrangements, the Company utilizes estimates of hours as a measure of progress to determine revenue.

Revenue from implementation services with employer customers is generally recognized as those services are performed.

Revenue from support and training fees is recognized over the service period.

Contracts with Multiple Performance Obligations

Certain of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the individual performance obligations are accounted for separately if they are distinct. The Company allocates the transaction price to the separate performance obligations based on their relative standalone selling prices. The Company determines the standalone selling prices based on its overall pricing objectives, taking into consideration market conditions and other factors, including the value of its contracts, the subscription services sold, customer size and complexity, and the number and types of users under the contracts.

Contract Costs

The Company capitalizes costs to obtain contracts that are considered incremental and recoverable, such as sales commissions. Payments of sales commissions generally include multiple payments. The Company capitalizes only those payments made within an insignificant time from the contract inception, typically three months or less. Subsequent payments are expensed as incurred. The capitalized costs are amortized to sales and marketing expense over the estimated period of benefit of the asset, which is generally four to five years. The Company expenses the costs to obtain a contract when the amortization period is less than one year. Deferred costs related to obtaining contracts are included in deferred contract costs and other non-current assets.

The Company capitalizes contract fulfillment costs directly associated with customer contracts that are not related to satisfying performance obligations. The costs are amortized to cost of revenue expense over the estimated period of benefit, which is generally five years. Deferred fulfillment costs are included in deferred contract costs and other non-current assets.

The following tables present information about deferred contract costs:

Balance of deferred contract costs

As of

March 31,

2020

As of

December 31,

2019

Costs to obtain contracts

6,205

6,676

Costs to fulfill contracts

3,055

3,112

	Three Months Ended March 31,
Amortization of deferred contract costs	2020		2019
Costs to obtain contracts included in sales and marketing expense	$	881	$	1,047
Costs to fulfill contracts included in cost of revenue	$	375	$	802

Concentrations of Credit Risk

The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash equivalents and accounts receivable. All of the Company’s cash and cash equivalents are held at financial institutions that management believes to be of high credit quality. The bank deposits of the Company might, at times, exceed federally insured limits and are generally uninsured and uncollateralized. The Company has not experienced any losses on cash and cash equivalents to date.

To manage accounts receivable risk, the Company evaluates the creditworthiness of its customers and maintains an allowance for doubtful accounts. Accounts receivable are unsecured and derived from revenue earned from customers located in the United States. Accounts receivable from one customer represented approximately 13% and 11% of the total accounts receivable as of March 31, 2020 and December 31, 2019, respectively. Accounts receivable from another customer represented approximately 10% of the total accounts receivable as of March 31, 2020. No other customer exceeded 10% of accounts receivable as of December 31, 2019. No customer exceeded 10% of total revenue in the three-month period ended March 31, 2020. Revenue from one customer was approximately 11% of the total revenue in the three-month period ended March 31, 2019.

Allowance for Doubtful Accounts

Historically, the Company used an incurred loss model to calculate its allowance for doubtful accounts. Upon the adoption of Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments” on January 1, 2020, the Company shifted to a current expected credit loss model. Accounts receivable and allowance for doubtful accounts are discussed in Note 5.

Capitalized Software Development Costs

The Company capitalizes certain costs related to its software developed or obtained for internal use. Costs related to preliminary project activities and post-implementation activities are expensed as incurred. Internal and external costs incurred during the application development stage, including upgrades and enhancements representing modifications that will result in significant additional functionality, are capitalized. Software maintenance and training costs are expensed as incurred. Capitalized costs are recorded as part of property and equipment and are amortized on a straight-line basis to cost of revenue over the software’s estimated useful life, which is three years. The Company evaluates these assets for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets.

The following tables present information about capitalized software development costs:

	Three Months Ended March 31,
Capitalized software development costs	2020		2019
Capitalized	$	3,472	$	2,063
Amortized	$	1,519	$	1,178

Capitalized software development costs

As of

March 31,

2020

As of

December 31,

2019

Net book value

16,412

14,459

Leases

The Company periodically enters into finance leases for property and equipment. The leasing arrangements for the Company’s office space at its headquarters campus are classified as finance leases. The Company also leases office space under operating leases.

The Company determines if an arrangement is a lease at inception. Right of use, or ROU, assets represent the Company’s right to use an underlying asset for the lease term. Lease liabilities represent an obligation to make lease payments arising from the lease. Leases with a term of 12 months or less are not included in the recognized ROU assets and lease liabilities for all classes of assets.

ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Because the Company’s operating leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on information available at commencement date to determine the present value of lease payments. The ROU asset also consists of any prepaid lease payments, lease incentives, or initial direct costs. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components (e.g. common area maintenance and equipment maintenance) that are accounted for as a single lease component. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as maintenance costs based on future obligations, are not included in the ROU assets or liabilities. These are expensed as incurred and recorded as variable lease expense.

Comprehensive Loss

The Company’s net loss equals comprehensive loss for all periods presented.

Recently Adopted Accounting Standards

Financial Instruments

On January 1, 2020, the Company adopted ASU No. 2016-13. The purpose of this ASU is to require a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected. Credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. On adoption, the Company recorded an immaterial cumulative-effect adjustment to retained earnings in connection with expected credit losses on its trade receivables.

Fair Value Measurement

On January 1, 2020 the Company adopted ASU No. 2018-13, “Fair Value Measurement (Topic 820): Changes to the Disclosure Requirements for Fair Value Measurement.” The ASU modifies the disclosure requirements required for fair value measurements. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

Accounting Standards Not Yet Adopted

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” ASU No. 2019-12 is intended to simplify various aspects related to accounting for income taxes, eliminates certain exceptions to the general principles in ASC Topic 740 related to intra-period tax allocation, simplifies when companies recognize deferred taxes in an interim period, and clarifies certain aspects of the current guidance to promote consistent application. This ASU is effective for the Company for the interim and annual reporting periods starting January 1, 2021. Early adoption is permitted. The Company is currently evaluating the potential effects of this guidance on its consolidated financial statements.

Net Loss Per Common Share

3 Months Ended

Mar. 31, 2020

Earnings Per Share [Abstract]

Net Loss Per Common Share

3. Net Loss Per Common Share

Diluted loss per common share is the same as basic loss per common share for all periods presented because the effects of potentially dilutive items were anti-dilutive given the Company’s net loss.

The following common share equivalent securities have been excluded from the calculation of weighted average common shares outstanding because the effect is anti-dilutive for the periods presented:

	Three Months Ended March 31,
Anti-Dilutive Common Share Equivalents	2020		2019
Restricted stock units		1,508,263		2,013,082
Stock options		179,363		214,647
Convertible senior notes		4,513,824		4,513,824
Employee Stock Purchase Plan		5,982		1,959
Total anti-dilutive common share equivalents		6,207,432		6,743,512

Basic and diluted net loss per common share is calculated as follows:

	Three Months Ended March 31,
	2020			2019
Numerator:
Net loss	$	(11,136	)	$	(14,209	)
Net loss attributable to common stockholders	$	(11,136	)	$	(14,209	)
Denominator:
Weighted-average common shares outstanding, basic and diluted		32,638,805			32,056,934
Net loss per common share, basic and diluted	$	(0.34	)	$	(0.44	)

Fair Value Measurement

3 Months Ended

Mar. 31, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurement

4. Fair Value Measurement

The carrying amounts of certain of the Company’s financial instruments, including cash and cash equivalents, accounts payable and other accrued liabilities, and accrued compensation and benefits, approximate fair value due to their short-term nature. The carrying value of the Company’s financing obligations approximates fair value, considering the borrowing rates currently available to the Company with similar terms and credit risks.

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs when determining fair value. The three tiers are defined as follows:

Level 1.

Quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2.

Other inputs that are directly or indirectly observable in the marketplace.

Level 3.

Unobservable inputs for which there is little or no market data, which require the Company to develop its own assumptions.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level to classify them for each reporting period. This determination requires significant judgments to be made.

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis using the above categories, as of the periods presented.

	March 31, 2020
Description	Level 1		Level 2		Level 3		Total
Cash Equivalents:
Money market mutual funds⁽¹⁾	$	112,199	$	—	$	—	$	112,199
Total assets	$	112,199	$	—	$	—	$	112,199

	December 31, 2019
Description	Level 1		Level 2		Level 3		Total
Cash Equivalents:
Money market mutual funds⁽¹⁾	$	124,503	$	—	$	—	$	124,503
Total assets	$	124,503	$	—	$	—	$	124,503

________________

(1)

Money market funds are classified as cash equivalents in the Company’s unaudited consolidated balance sheets. As short-term, highly liquid investments readily convertible to known amounts of cash with remaining maturities of three months or less at the time of purchase, the Company’s cash equivalent money market funds have carrying values that approximate fair value.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Accounts receivable, Net

3 Months Ended

Mar. 31, 2020

Accounts Receivable Net [Abstract]

Accounts Receivable, Net

5. Accounts Receivable, net

Accounts receivable, net include:

	As of March 31, 2020			As of December 31, 2019
Accounts receivable	$	37,022		$	36,669
Less: Allowance for doubtful accounts		(242	)		(155	)
Less: Allowance for returns		(3,330	)		(2,760	)
Total accounts receivable, net	$	33,450		$	33,754

Accounts receivable are stated at their amortized cost adjusted for any write-offs and net allowances for returns. The Company estimates expected credit losses related to accounts receivable balances based on a review of available and relevant information including current economic conditions, projected economic conditions, historical loss experience, account aging, and other factors that could affect collectability. Expected credit losses are determined individually or collectively depending on whether the accounts receivable balances share similar risk characteristics. The allowance for doubtful accounts is the best estimate of the amount of expected credit losses related to existing accounts receivable. The Company does not have any off-balance sheet credit exposure related to its customers.

Allowance for doubtful accounts	Three Months Ended March 31, 2020
Beginning of period	$	155
Provision for credit losses (including effect of adoption)		131
Write-offs and recoveries		(44	)
End of period	$	242

The allowances for returns are accounted for as reductions of revenue and are estimated based on the Company’s periodic assessment of historical experience and trends. The Company considers factors such as historical reasons for adjustments, service and delivery issues or delays, and past due customer billings.

Convertible Senior Notes

3 Months Ended

Mar. 31, 2020

Debt Disclosure [Abstract]

Convertible Senior Notes

6. Convertible Senior Notes

In December 2018, the Company issued $240,000 aggregate principal amount of 1.25% convertible senior notes (“Notes”) due December 15, 2023, unless earlier repurchased by the Company or converted by the holder pursuant to their terms. Interest is payable semiannually in arrears on June 15 and December 15 of each year, commencing on June 15, 2019.

The Notes are governed by an Indenture between the Company, as issuer, and U.S. Bank, National Association, as trustee. The Notes are unsecured and rank: senior in right of payment to the Company’s future indebtedness that is expressly subordinated in right of payment to the Notes; equal in right of payment to the Company’s unsecured indebtedness that is not subordinated; effectively junior in right of payment to any of the Company’s senior, secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities incurred by the Company’s subsidiaries.

Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company’s common stock or a combination of cash and shares of common stock, at the Company’s election.

The Notes have an initial conversion rate of 18.8076 shares of common stock per $1 principal amount of Notes. This represents an initial effective conversion price of approximately $53.17 per share of common stock and 4,513,824 shares issuable upon conversion. Throughout the term of the Notes, the conversion rate may be adjusted upon the occurrence of certain events. Holders of the Notes will not receive any cash payment representing accrued and unpaid interest, if any, upon conversion of a Note, except in limited circumstances. Accrued but unpaid interest will be deemed to be paid by cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock paid or delivered, as the case may be, to the holder upon conversion of Notes.

Prior to the close of business on September 14, 2023, the Notes will be convertible at the option of holders during certain periods, only upon satisfaction of certain conditions set forth below. On or after September 15, 2023, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes at the conversion price at any time regardless of whether the conditions set forth below have been met.

Holders may convert all or a portion of their Notes prior to the close of business on September 14, 2023, in multiples of $1 principal amount, only under the following circumstances:

•

during any calendar quarter commencing after the calendar quarter ending on March 31, 2019 (and only during such calendar quarter), if the last reported sales price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

•

during the five business day period after any five consecutive trading day period, or the Notes measurement period, in which the “trading price” (as defined in the Indenture) per $1 principal amount of notes for each trading day of the Notes measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day;

•

if the Company calls any or all of the Notes for redemption, at any time prior to the close of business on September 14, 2023; or

•

upon the occurrence of specified corporate events.

As of March 31, 2020, the Notes were not convertible.

Based on market data available for publicly traded, senior, unsecured corporate bonds issued by companies in the same industry and with similar maturity, the Company estimated the implied market interest rate of its Notes to be approximately 7.30%, assuming no conversion option. Assumptions used in the estimate represent what market participants would use in pricing the liability component of the Notes, including market interest rates, credit standing, and yield curves, all of which are defined as Level 2 observable inputs. The estimated implied interest rate was applied to the Notes, which resulted in a fair value of the liability component of $181,500 upon issuance, calculated as the present value of future contractual payments based on the $240,000 aggregate principal amount. The excess of the principal amount of the liability component over its carrying amount, or the debt discount, is amortized to interest expense over the term of the Notes. The $58,500 difference between the gross proceeds received from issuance of the Notes of $240,000 and the estimated fair value of the liability component represents the equity component of the Notes and was recorded in additional paid-in capital. The equity component is not remeasured as long as it continues to meet the conditions for equity classification.

In accounting for the transaction costs related to the issuance of the Notes, the Company allocated the total amount incurred to the liability and equity components in proportion to the allocation of proceeds. Transaction costs attributable to the liability component, totaling $4,808, are being amortized to expense over the term of the Notes, and transaction costs attributable to the equity component, totaling $1,550, and were included with the equity component in shareholders’ equity.

The Notes consist of the following as of:

	As of
	March 31, 2020			December 31, 2019
Liability component:
Principal	$	240,000		$	240,000
Less: Debt discount, net of amortization		(49,127	)		(52,051	)
Net carrying amount	$	190,873		$	187,949
Equity component (a)		56,950			56,950

(a)

Recorded in the consolidated balance sheet within additional paid-in capital, net of $1,550 transaction costs in equity.

The following table sets forth total interest expense recognized related to the Notes:

	Three Months Ended March 31,
	2020		2019
1.25% coupon	$	750	$	750
Amortization of debt discount and transaction costs		2,924		2,749
	$	3,674	$	3,499

As of March 31, 2020, the fair value of the Notes, which was determined based on inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, quoted price of the Notes in an over-the-counter market (Level 2), and carrying value of debt instruments (carrying value excludes the equity component of the Company’s Notes classified in equity) were as follows:

	March 31, 2020				December 31, 2019
	Fair Value		Carrying Value		Fair Value		Carrying Value
Convertible senior notes	$	180,000	$	190,873	$	207,600	$	187,949

In connection with the issuance of the Notes, the Company entered into capped call transactions with certain counterparties affiliated with the initial purchasers and others. The capped call transactions are expected to reduce potential dilution of earnings per share upon conversion of the Notes. Under the capped call transactions, the Company purchased capped call options that in the aggregate relate to the total number of shares of the Company’s common stock underlying the Notes, with an initial strike price of approximately $53.17 per share, which corresponds to the initial conversion price of the Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Notes, and have a cap price of approximately $89.98. The cost of the purchased capped calls of $33,024 was recorded to stockholders’ deficit and will not be re-measured provided it continues to meet the conditions for equity classification.

Based on the closing price of our common stock of $8.91 on March 31, 2020, the last trading day of the quarter, the if-converted value of the Notes was less than their respective principal amounts.

Revolving Line of Credit

3 Months Ended

Mar. 31, 2020

Debt Disclosure [Abstract]

Revolving Line of Credit

7. Revolving Line of Credit

On February 20, 2020, the Company’s Senior Revolver expired. Other than unused line fees, which have all been paid, there was no outstanding indebtedness under the Senior Revolver when it expired.

On March 3, 2020, the Company entered into a new credit facility with Silicon Valley Bank providing for a revolving line of credit agreement. The three-year agreement has a borrowing limit of $50,000, with the ability for the Company to increase it to up to $100,000. Interest is payable monthly. Advances under the agreement bear interest at (a) the higher of (i) the prime rate as published in the Wall Street Journal or (ii) the federal funds effective rate plus 0.50%, plus (b) an applicable margin ranging from (0.50%) to 0.50% based on the Company’s Average Daily Usage (“ADU”) of the credit facility in the preceding month. The Company also is charged for amounts unused under this arrangement at a rate ranging from 0.00% to 0.40% based on the Company’s ADU in the preceding month. Any outstanding principal is due at the end of the term.

The obligations of the Company under the new credit facility are secured by a first priority lien (subject to certain permitted liens) in substantially all of the personal property assets of the Company and its subsidiaries pursuant to the terms of a Guarantee and Collateral Agreement, dated March 3, 2020 and the other security documents.

The new credit facility contains customary representations and warranties and restrictive covenants. In addition, the Company is required to maintain a Consolidated Adjusted Quick Ratio (“AQR”) of (i) Consolidated Quick Assets to (ii) Consolidated Current Liabilities minus the current portion of Deferred Revenue of at least 1.25 to 1.00 as of the last day of any fiscal quarter, and, if the AQR is less than 2.00 to 1.00, a Minimum Consolidated EBITDA of at least $1.00 for any such fiscal quarter calculated on a trailing 12 month basis. The Company has also agreed to fiscal year dollar limits on its capital expenditures.

The new credit facility contains customary events of default, including payment and covenant defaults (subject to grace and cure periods), breaches of representations and warranties, defaults under certain other indebtedness, change of control, insolvency events, and the occurrence of a material adverse effect. If an event of default occurs, the lender would be entitled to take various actions, including the acceleration of amounts due under the credit facility and all actions permitted to be taken by a secured creditor.

As of March 31, 2020, the amount outstanding under the Company’s revolving line of credit was $10,000. The amount available to borrow was $40,000 and the interest rate was 2.75% as of March 31, 2020. In March 2020, the Company borrowed $10,000 under its line of credit for general operating purposes.

Commitments

3 Months Ended

Mar. 31, 2020

Commitments And Contingencies Disclosure [Abstract]

Commitments

8. Commitments

Supplemental cash flow information related to the Company’s operating and finance leases was as follows:

Cash Paid for Amounts Included in the Measurement of Lease Liabilities	Three Months Ended March 31, 2020
Financing cash flows from finance leases	$	5,600
Operating cash flows from finance leases	$	2,067
Operating cash flows from operating leases	$	195
ROU Assets Obtained in Exchange for New Lease Obligations
Finance lease liabilities	$	3,593
Operating lease liabilities	$	-

As of March 31, 2020, the Company had no additional significant operating or finance leases that had not yet commenced.

Finance Leases

On March 13, 2020, the Company executed an amendment to its three leases for office space on its headquarters campus. Pursuant to this amendment, the Company paid the lessor, a related party, $3,993 for future rent due in the first half of 2021, representing an approximately 17% discount on rent due for those periods. The ROU assets and financing lease liabilities were adjusted to reflect the effect of the amendment and associated payments.

In February 2020, the Company entered into a financing lease arrangement for servers and networking equipment used in operations. Total payments under the agreement are $3,723, including the first annual payment of $784 and two annual payments of $1,470, each. In connection with this lease, the Company recorded financing ROU assets and financing lease liabilities of $3,593.

Stock-based Compensation

3 Months Ended

Mar. 31, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock-based Compensation

9. Stock-based Compensation

Restricted Stock Units

During the three months ended March 31, 2020, the Company granted 49,800 restricted stock units, or RSUs, to employees and officers with an aggregate grant date fair value of $890. These RSUs generally vest in equal annual installments over various periods ranging from less than one year to up to four years from the grant date, subject to continued service to the Company. The Company amortizes the grant date fair value of the stock subject to the RSUs on a straight-line basis over the period of vesting. The weighted-average vesting period for these RSUs is approximately 3.88 years from the date of grant.

Stockholders' Deficit

3 Months Ended

Mar. 31, 2020

Equity [Abstract]

Stockholders' Deficit

10. Stockholders’ Deficit

Common Stock

The holders of common stock are entitled to one vote for each share. The voting, dividend and liquidation rights of the holders of common stock are subject to and qualified by the rights, powers and preferences of the holders of preferred stock.

At March 31, 2020, the Company had reserved a total of 5,415,582 of its authorized 50,000,000 shares of common stock for future issuance as follows:

Outstanding stock options			179,363
Restricted stock units			1,508,263
Available for future issuance under stock award plans			3,622,233
Available for future issuance under ESPP			105,723
Total common shares reserved for future issuance			5,415,582

Under its stock repurchase program, the Company purchased 1,070,665 shares of its outstanding common stock, for an aggregate of $9,383 during the three months ended March 31, 2020. Of these shares, 1,067,804 have been canceled and returned to its pool of authorized shares to be used for general purposes. The balance of shares repurchased, if any, will be canceled in future periods. As of March 31, 2020, approximately $10,617 remains available for potential repurchases.

Revenue

3 Months Ended

Mar. 31, 2020

Revenue From Contract With Customer [Abstract]

Revenue

11. Revenue

Disaggregation of Revenue

The following tables provide information about disaggregation of revenue by service line:

	Three Months Ended March 31,
	2020		2019
Service line:
Subscription	$	45,990	$	47,869
Platform		6,005		5,143
Total software services	$	51,995	$	53,012
Professional services		14,159		15,287
Total	$	66,154	$	68,299

Contract Balances

The following table provides information about contract assets and contract liabilities from contracts with customers:

	Balance at Beginning of Period		Balance at End of Period
Three Months Ended March 31, 2020
Contract assets	$	16,685	$	13,870
Contract liabilities:
Deferred revenue	$	38,508	$	34,539

Three Months Ended March 31, 2019
Contract assets	$	12,798	$	12,383
Contract liabilities:
Deferred revenue	$	45,863	$	46,895

The Company recognizes payments from customers based on contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company’s contractual right to consideration for completed performance objectives not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are recognized as revenue when earned under the contract. The Company had no asset impairment charges related to contract assets during the three months ended March 31, 2020 and 2019.

There were no significant changes in the contract assets outside of standard revenue and billing activity.

Revenue recognized during the three months ended March 31, 2020 that was included in the deferred revenue balance at the beginning of the period was $19,766.

The Company recorded favorable adjustments to revenue arising from performance obligations satisfied or partially satisfied in previous periods $660 during the three months ended March 31, 2020.

Performance Obligations

As of March 31, 2020, the aggregate amount of the Company’s performance obligations that are unsatisfied or partially unsatisfied were approximately $190,000, of which a majority are expected to be satisfied within the next three years. The Company excludes from its population of performance obligations contracts with original durations of one year or less, contract renewal periods that renew automatically, and amounts of variable consideration that are allocated to wholly unsatisfied distinct service that forms part of a single performance obligation and meets certain variable allocation criteria.

Income Taxes

3 Months Ended

Mar. 31, 2020

Income Tax Disclosure [Abstract]

Income Taxes

12. Income Taxes

The Company’s effective federal tax rate for the three months ended March 31, 2020 was less than one percent, primarily as a result of estimated tax losses for the fiscal year to date offset by the increase in the valuation allowance in the net operating loss carryforwards. Current tax expense relates to estimated state income taxes.

Segments and Geographic Information

3 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Segments and Geographic Information

13. Segments and Geographic Information

The Company views its operations and manages its business as one operating segment. Segment information matches the consolidated financial information for the current period and prior periods reported.

Related Parties

3 Months Ended

Mar. 31, 2020

Related Parties

14. Related Parties

Related Party Leasing Arrangements

The Company leases its office space at its Charleston, South Carolina headquarters campus under the terms of three non-cancellable leases from entities affiliated with an executive who is also a Company director and significant stockholder. The Company’s headquarter campus building leases are accounted for as financing lease right-of-use assets and lease liabilities on the Consolidated Balance Sheet as of March 31, 2020. The three lease agreements have 15-year terms ending on December 31, 2031, with Company options to renew for five additional years. The arrangements provide for 3.0% fixed annual rent increases. Payments under these agreements were $7,358 and $3,331 for the three months ended March 31, 2020 and 2019, respectively. Other amounts due to these related parties were $209 and $791 as of March 31, 2020 and December 31, 2019, respectively, and were recorded in “Accrued expenses.” Payments made for the three months ended March 31, 2020 include amounts paid in connection with the amendment of these leases discussed in Note 8.

Other Related Party Expenses

The Company utilizes the services of various companies that are owned and controlled by an executive who is also a Company director and significant stockholder. The companies provide construction project management services, private air transportation and other services. Expenses related to these companies were $120 and $119 for the three months ended March 31, 2020 and 2019, respectively. There were no amounts due to these companies as of March 31, 2020 and December 31, 2019.

During 2018, the Company entered into an agreement to purchase software and services from a company affiliated with a Company director. The aggregate amount of payments due under this contract is $115. Payments related to this agreement were $26 and $35 for the three months ended March 31, 2020 and 2019, respectively. Amounts due to this company were $26 as of March 31, 2020. There were no amounts due to this company as of December 31, 2019.

Subsequent Events

3 Months Ended

Mar. 31, 2020

Subsequent Events [Abstract]

Subsequent Events

15. Subsequent Events

Restricted Stock Units

During May 2020, the Company granted 1,225,460 RSUs and 785,596 performance RSUs with an aggregate grant date fair value of $12,524 and $8,029, respectively. The aggregate grant date fair value of the performance RSUs assuming target achievement was $6,206. The RSUs generally vest in equal annual installments over four years from the grant date. The number of performance RSUs that will vest will be determined upon the achievement of certain financial targets for 2020, and vesting will then occur in equal annual installments over various periods ranging from less than one to three years. The actual number of shares issued upon vesting could range between 0% and 100% of the number of awards granted. The weighted-average vesting period for these RSUs and performance RSUs is approximately 3.09 and 2.36 years from the date of grant, respectively.

Common Stock

During April and May 2020, employees exercised stock options and RSUs vested resulting in the issuance of 288,232 shares.

The Company purchased 35,508 shares of its outstanding common stock for an aggregate of $285 during April 2020.

COVID-19 Pandemic

On March 11, 2020, the World Health Organization classified the COVID-19 outbreak as a pandemic. The pandemic did not have a material impact on the Company’s financial statements for the three months ended March 31, 2020. The Company has implemented actions to maintain its financial health and liquidity. The Company is also monitoring the impacts of COVID-19 on the fair value of assets. Future changes in sales, earnings and cash flows related to long-lived assets to be held and used and goodwill could cause these assets to become impaired. In addition, the Company continues to monitor the impacts of the pandemic on its estimates for allowance for doubtful accounts and expected credit losses associated with its accounts receivable and certain contract assets. COVID-19 is discussed in more detail throughout “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

Restructuring Plan

On April 28, 2020, the Company announced a restructuring plan to as part of the Company’s actions to ensure the safety and well-being of its employees and customers, contain costs and further preserve its liquidity profile in response to the impact of the COVID-19 pandemic. This plan entailed a reduction in U.S. workforce of approximately 17% in the second quarter of 2020. The Company estimates that the restructuring plan will result in pre-tax charges of approximately $5,000 to $7,000 and will be recorded as restructuring expenses in the second quarter of 2020. The charges will consist of one-time severance charges, acceleration of unvested equity grants, continuation of health benefits and outplacement services. The estimated cash expenditure for these charges is approximately $5,000.

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Principles of Consolidation

Interim Unaudited Consolidated Financial Information

Use of Estimates

Revenue and Deferred Revenue

The Company determines revenue recognition through the following steps:

•

Identification of each contract with a customer;

•

Identification of the performance obligations in the contract;

•

Determination of the transaction price;

•

Allocation of the transaction price to the performance obligations in the contract; and

•

Recognition of revenue when, or as, performance obligations are satisfied.

Software Services Revenue

Software services revenue consists of subscription revenue and platform revenue.

Subscription Revenue

Subscription revenue also includes fees paid for other services, such as event sponsorships and certain data services.

Platform Revenue

Professional Services Revenue

Revenue from implementation services with employer customers is generally recognized as those services are performed.

Revenue from support and training fees is recognized over the service period.

Contracts with Multiple Performance Obligations

Contract Costs

The following tables present information about deferred contract costs:

Balance of deferred contract costs

As of

March 31,

2020

As of

December 31,

2019

Costs to obtain contracts

6,205

6,676

Costs to fulfill contracts

3,055

3,112

	Three Months Ended March 31,
Amortization of deferred contract costs	2020		2019
Costs to obtain contracts included in sales and marketing expense	$	881	$	1,047
Costs to fulfill contracts included in cost of revenue	$	375	$	802

Concentrations of Credit Risk

Accounts Receivable and Allowance for Doubtful Accounts and Returns

Allowance for Doubtful Accounts

Capitalized Software Development Costs

The following tables present information about capitalized software development costs:

	Three Months Ended March 31,
Capitalized software development costs	2020		2019
Capitalized	$	3,472	$	2,063
Amortized	$	1,519	$	1,178

Capitalized software development costs

As of

March 31,

2020

As of

December 31,

2019

Net book value

16,412

14,459

Leases

Comprehensive Loss

The Company’s net loss equals comprehensive loss for all periods presented.

Recently Adopted Accounting Standards

Financial Instruments

Fair Value Measurement

Accounting Standards Not Yet Adopted

Summary Of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2020

Accounting Policies [Abstract]

Schedule of Deferred Contract Costs

The following tables present information about deferred contract costs:

Balance of deferred contract costs

As of

March 31,

2020

As of

December 31,

2019

Costs to obtain contracts

6,205

6,676

Costs to fulfill contracts

3,055

3,112

	Three Months Ended March 31,
Amortization of deferred contract costs	2020		2019
Costs to obtain contracts included in sales and marketing expense	$	881	$	1,047
Costs to fulfill contracts included in cost of revenue	$	375	$	802

Schedule of Capitalized Software Development Costs

The following tables present information about capitalized software development costs:

	Three Months Ended March 31,
Capitalized software development costs	2020		2019
Capitalized	$	3,472	$	2,063
Amortized	$	1,519	$	1,178

Capitalized software development costs

As of

March 31,

2020

As of

December 31,

2019

Net book value

16,412

14,459

Net Loss Per Common Share (Tables)

3 Months Ended

Mar. 31, 2020

Earnings Per Share [Abstract]

Common Share Equivalent Securities Excluded from Calculation of Weighted-Average Common Shares Outstanding

The following common share equivalent securities have been excluded from the calculation of weighted average common shares outstanding because the effect is anti-dilutive for the periods presented:

	Three Months Ended March 31,
Anti-Dilutive Common Share Equivalents	2020		2019
Restricted stock units		1,508,263		2,013,082
Stock options		179,363		214,647
Convertible senior notes		4,513,824		4,513,824
Employee Stock Purchase Plan		5,982		1,959
Total anti-dilutive common share equivalents		6,207,432		6,743,512

Basic and Diluted Net Loss per Common Share

Basic and diluted net loss per common share is calculated as follows:

	Three Months Ended March 31,
	2020			2019
Numerator:
Net loss	$	(11,136	)	$	(14,209	)
Net loss attributable to common stockholders	$	(11,136	)	$	(14,209	)
Denominator:
Weighted-average common shares outstanding, basic and diluted		32,638,805			32,056,934
Net loss per common share, basic and diluted	$	(0.34	)	$	(0.44	)

Fair Value Measurement (Tables)

3 Months Ended

Mar. 31, 2020

Fair Value Disclosures [Abstract]

Assets and Liabilities Measured at Fair Value on Recurring Basis

The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis using the above categories, as of the periods presented.

	March 31, 2020
Description	Level 1		Level 2		Level 3		Total
Cash Equivalents:
Money market mutual funds⁽¹⁾	$	112,199	$	—	$	—	$	112,199
Total assets	$	112,199	$	—	$	—	$	112,199

	December 31, 2019
Description	Level 1		Level 2		Level 3		Total
Cash Equivalents:
Money market mutual funds⁽¹⁾	$	124,503	$	—	$	—	$	124,503
Total assets	$	124,503	$	—	$	—	$	124,503

________________

(1)

Accounts receivable, Net (Tables)

3 Months Ended

Mar. 31, 2020

Accounts Receivable Net [Abstract]

Summary of Account Receivable, Net

Accounts receivable, net include:

	As of March 31, 2020			As of December 31, 2019
Accounts receivable	$	37,022		$	36,669
Less: Allowance for doubtful accounts		(242	)		(155	)
Less: Allowance for returns		(3,330	)		(2,760	)
Total accounts receivable, net	$	33,450		$	33,754

Schedule of Allowance for Doubtful Accounts

Allowance for doubtful accounts	Three Months Ended March 31, 2020
Beginning of period	$	155
Provision for credit losses (including effect of adoption)		131
Write-offs and recoveries		(44	)
End of period	$	242

Convertible Senior Notes (Tables)

3 Months Ended

Mar. 31, 2020

Debt Disclosure [Abstract]

Schedule of Convertible Notes

The Notes consist of the following as of:

	As of
	March 31, 2020			December 31, 2019
Liability component:
Principal	$	240,000		$	240,000
Less: Debt discount, net of amortization		(49,127	)		(52,051	)
Net carrying amount	$	190,873		$	187,949
Equity component (a)		56,950			56,950

(a)

Recorded in the consolidated balance sheet within additional paid-in capital, net of $1,550 transaction costs in equity.

Summary of Recognized Interest Expense

The following table sets forth total interest expense recognized related to the Notes:

	Three Months Ended March 31,
	2020		2019
1.25% coupon	$	750	$	750
Amortization of debt discount and transaction costs		2,924		2,749
	$	3,674	$	3,499

Schedule of Fair Value and Carrying Value of Convertible Senior Notes

	March 31, 2020				December 31, 2019
	Fair Value		Carrying Value		Fair Value		Carrying Value
Convertible senior notes	$	180,000	$	190,873	$	207,600	$	187,949

Commitments (Tables)

3 Months Ended

Mar. 31, 2020

Leases [Abstract]

Schedule of Supplemental Cash Flow Information Related to Operating and Finance Leases

Supplemental cash flow information related to the Company’s operating and finance leases was as follows:

Cash Paid for Amounts Included in the Measurement of Lease Liabilities	Three Months Ended March 31, 2020
Financing cash flows from finance leases	$	5,600
Operating cash flows from finance leases	$	2,067
Operating cash flows from operating leases	$	195
ROU Assets Obtained in Exchange for New Lease Obligations
Finance lease liabilities	$	3,593
Operating lease liabilities	$	-

Stockholders' Deficit (Tables)

3 Months Ended

Mar. 31, 2020

Equity [Abstract]

Shares of Common Stock Reserved for Future Issuance

At March 31, 2020, the Company had reserved a total of 5,415,582 of its authorized 50,000,000 shares of common stock for future issuance as follows:

Outstanding stock options			179,363
Restricted stock units			1,508,263
Available for future issuance under stock award plans			3,622,233
Available for future issuance under ESPP			105,723
Total common shares reserved for future issuance			5,415,582

Revenue (Tables)

3 Months Ended

Mar. 31, 2020

Revenue From Contract With Customer [Abstract]

Summary of Disaggregation of Revenue by Service Line

The following tables provide information about disaggregation of revenue by service line:

	Three Months Ended March 31,
	2020		2019
Service line:
Subscription	$	45,990	$	47,869
Platform		6,005		5,143
Total software services	$	51,995	$	53,012
Professional services		14,159		15,287
Total	$	66,154	$	68,299

Summary of Contract Assets and Contract Liabilities

The following table provides information about contract assets and contract liabilities from contracts with customers:

	Balance at Beginning of Period		Balance at End of Period
Three Months Ended March 31, 2020
Contract assets	$	16,685	$	13,870
Contract liabilities:
Deferred revenue	$	38,508	$	34,539

Three Months Ended March 31, 2019
Contract assets	$	12,798	$	12,383
Contract liabilities:
Deferred revenue	$	45,863	$	46,895

Summary of Significant Accounting Policies - Additional Information (Detail) - Customer	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Summary Of Significant Accounting Policies [Line Items]
Contract cost payments, description	The Company capitalizes only those payments made within an insignificant time from the contract inception, typically three months or less. Subsequent payments are expensed as incurred. The capitalized costs are amortized to sales and marketing expense over the estimated period of benefit of the asset, which is generally four to five years. The Company expenses the costs to obtain a contract when the amortization period is less than one year.
Capitalized Software Development Costs
Summary Of Significant Accounting Policies [Line Items]
Useful lives for property and equipment	3 years
Accounts Receivable
Summary Of Significant Accounting Policies [Line Items]
No of Custumer	1		1
Accounts Receivable \| Other Customer
Summary Of Significant Accounting Policies [Line Items]
No of Custumer			0
Total Revenue
Summary Of Significant Accounting Policies [Line Items]
No of Custumer	0	1
Customer Concentration Risk \| Accounts Receivable
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage	13.00%		11.00%
Customer Concentration Risk \| Accounts Receivable \| Other Customer
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage	10.00%		10.00%
Customer Concentration Risk \| Total Revenue
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage	10.00%	11.00%
Cost of Revenue
Summary Of Significant Accounting Policies [Line Items]
Estimated amortization period of contract costs	5 years
Minimum \| Sales and Marketing Expense
Summary Of Significant Accounting Policies [Line Items]
Estimated amortization period of contract costs	4 years
Maximum \| Sales and Marketing Expense
Summary Of Significant Accounting Policies [Line Items]
Estimated amortization period of contract costs	5 years

Schedule of Deferred Contract Costs (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Condensed Income Statements Captions [Line Items]
Deferred contract costs and other non-current assets	$ 10,445		$ 11,002
Sales and Marketing Expense
Condensed Income Statements Captions [Line Items]
Deferred contract costs and other non-current assets	6,205		6,676
Costs to obtain contracts included in sales and marketing expense	881	$ 1,047
Cost of Revenue
Condensed Income Statements Captions [Line Items]
Deferred contract costs and other non-current assets	3,055		$ 3,112
Costs to obtain contracts included in sales and marketing expense	$ 375	$ 802

Schedule of Capitalized Software Development Costs (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Accounting Policies [Abstract]
Capitalized	$ 3,472	$ 2,063
Amortized	1,519	$ 1,178
Net book value	$ 16,412		$ 14,459

Common Share Equivalents Securities Excluded from Calculation of Weighted Average Common Share Outstanding (Detail) - shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common share equivalents	6,207,432	6,743,512
Restricted Stock Units (RSUs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common share equivalents	1,508,263	2,013,082
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common share equivalents	179,363	214,647
Convertible Senior Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common share equivalents	4,513,824	4,513,824
Employee Stock Purchase Plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common share equivalents	5,982	1,959

Basic and Diluted Net Loss per Common Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Numerator:
Net loss	$ (11,136)	$ (14,209)
Net loss attributable to common stockholders	$ (11,136)	$ (14,209)
Denominator:
Weighted-average common shares outstanding, basic and diluted	32,638,805	32,056,934
Net loss per common share, basic and diluted	$ (0.34)	$ (0.44)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) - Fair Value, Measurements, Recurring - USD ($)
$ in Thousands

Mar. 31, 2020

Dec. 31, 2019

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Total assets

$ 112,199

$ 124,503

Money market mutual funds

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Cash Equivalents

^[1]

112,199

124,503

Level 1

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Total assets

112,199

124,503

Level 1 | Money market mutual funds

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Cash Equivalents

^[1]

112,199

124,503

Level 2

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Total assets

Level 2 | Money market mutual funds

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Cash Equivalents

^[1]

Level 3

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Total assets

Level 3 | Money market mutual funds

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Cash Equivalents

^[1]

$ 0

[1]

Summary of Account Receivable, Net (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Accounts Receivable Net [Abstract]
Accounts receivable	$ 37,022	$ 36,669
Less: Allowance for doubtful accounts	(242)	(155)
Less: Allowance for returns	(3,330)	(2,760)
Total accounts receivable, net	$ 33,450	$ 33,754

Schedule of Allowance for Doubtful Accounts (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2020 USD ($)
Accounts Receivable Net [Abstract]
Beginning of period	$ 155
Provision for credit losses (including effect of adoption)	131
Write-offs and recoveries	(44)
End of period	$ 242

Convertible Senior Notes - Additional Information (Detail)	1 Months Ended	3 Months Ended
	Dec. 31, 2018 USD ($)	Mar. 31, 2020 USD ($) shares Day $ / shares	Dec. 31, 2019 USD ($)
Common Stock
Debt Instrument [Line Items]
Closing price of our common stock \| $ / shares		$ 8.91
1.25% Convertible Senior Notes
Debt Instrument [Line Items]
Debt instrument, aggregate principal amount	$ 240,000,000	$ 240,000,000	$ 240,000,000
Debt instrument, interest rate	1.25%
Debt instrument, maturity date	Dec. 15, 2023
Initial effective conversion price of debt instrument \| $ / shares		$ 1
Consecutive trading period \| Day		5
Interest rate conversion notes		7.30%
Fair value of the liability conversion notes		$ 181,500,000
Gross proceeds received from issuance of the notes		240,000,000
Difference between gross proceeds received from issuance of the notes and estimated fair value of notes		58,500,000
Transaction costs attributable to the liability component		4,808,000
Transaction costs attributable to the equity component		$ 1,550,000
1.25% Convertible Senior Notes \| Call Option
Debt Instrument [Line Items]
Initial strike price \| $ / shares		53.17
Cap price \| $ / shares		89.98
Purchase of convertible note capped call hedge		$ 33,024
1.25% Convertible Senior Notes \| Maximum
Debt Instrument [Line Items]
Conversion price percentage		1.30
Percent of Senior notes Principal amount to trigger Conversion as product of stock price and conversion rate		98.00%
1.25% Convertible Senior Notes \| Common Stock
Debt Instrument [Line Items]
Debt instrument, conversion ratio		18.8076
Initial effective conversion price of debt instrument \| $ / shares		$ 53.17
Number shares issuable upon conversion \| shares		4,513,824

Schedule of Convertible Notes (Detail) - 1.25% Convertible Senior Notes - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Principal	$ 240,000	$ 240,000	$ 240,000
Less: Debt discount, net of amortization	(49,127)	(52,051)
Net carrying amount	190,873	187,949
Equity component (a)	$ 56,950	$ 56,950

Schedule of Convertible Notes (Parenthetical) (Detail) - 1.25% Convertible Senior Notes $ in Thousands	Mar. 31, 2020 USD ($)
Debt Instrument [Line Items]
Transaction costs attributable to the equity component	$ 1,550
Additional Paid-in Capital
Debt Instrument [Line Items]
Transaction costs attributable to the equity component	$ 1,550

Summary of Recognized Interest Expense (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Debt Instrument [Line Items]
Interest expense	$ 5,891	$ 5,814
1.25% Convertible Senior Notes
Debt Instrument [Line Items]
1.25% coupon	750	750
Amortization of debt discount and transaction costs	2,924	2,749
Interest expense	$ 3,674	$ 3,499

Schedule of Fair Value and Carrying Value of Convertible Senior Notes (Detail) - 1.25% Convertible Senior Notes - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Fair Value	$ 180,000	$ 207,600
Carrying Value	$ 190,873	$ 187,949

Revolving Line of Credit - Additional Information (Detail) - USD ($) $ in Thousands		3 Months Ended
	Mar. 03, 2020	Mar. 31, 2020
Revolving Line of Credit Agreement \| Silicon Valley Bank
Line Of Credit Facility [Line Items]
Line of credit facility, expiration period	3 years
Line of credit facility current maximum borrowing capacity	$ 50,000
Line of credit facility expanded maximum borrowing capacity	$ 100,000
Description of customary representations and warranties and restrictive covenants	Company is required to maintain a Consolidated Adjusted Quick Ratio (“AQR”) of (i) Consolidated Quick Assets to (ii) Consolidated Current Liabilities minus the current portion of Deferred Revenue of at least 1.25 to 1.00 as of the last day of any fiscal quarter, and, if the AQR is less than 2.00 to 1.00, a Minimum Consolidated EBITDA of at least $1.00 for any such fiscal quarter calculated on a trailing 12 month basis. The Company has also agreed to fiscal year dollar limits on its capital expenditures.
Federal funds effective rate plus	0.50%
Revolving Line of Credit Agreement \| Silicon Valley Bank \| Minimum
Line Of Credit Facility [Line Items]
Interest rate margin to be added on prime rate	(0.50%)
Line of credit facility, unused capacity, commitment fee percentage	0.00%
Adjusted Quick Ratio	1.25
EBITDA	1.00
Revolving Line of Credit Agreement \| Silicon Valley Bank \| Maximum
Line Of Credit Facility [Line Items]
Interest rate margin to be added on prime rate	0.50%
Line of credit facility, unused capacity, commitment fee percentage	0.40%
Adjusted Quick Ratio	2.00
Senior Revolving Line of Credit
Line Of Credit Facility [Line Items]
Line of credit facility expiration date	Feb. 20, 2020
Amount outstanding under credit facility	$ 0	$ 10,000
Line of credit facility current borrowing capacity available		$ 40,000
Interest rate		2.75%
Amount borrowed under its line of credit for general operating purposes		$ 10,000

Schedule of Supplemental Cash Flow Information Related to Operating and Finance Leases (Detail) - USD ($) $ in Thousands		3 Months Ended
	Mar. 13, 2020	Mar. 31, 2020
Cash Paid for Amounts Included in the Measurement of Lease Liabilities
Financing cash flows from finance leases	$ 3,993	$ 5,600
Operating cash flows from finance leases		2,067
Operating cash flows from operating leases		195
ROU Assets Obtained in Exchange for New Lease Obligations
Finance lease liabilities		3,593
Operating lease liabilities		$ 0

Commitments - Additional Information (Detail) $ in Thousands		3 Months Ended
	Mar. 13, 2020 USD ($) Lease	Mar. 31, 2020 USD ($)	Feb. 29, 2020 USD ($)	Dec. 31, 2019 USD ($)
Commitments And Contingencies Disclosure [Abstract]
Payment for future rent due in the first half of 2021	$ 3,993	$ 5,600
Number of leases for office space \| Lease	3
Percentage of discount rate on rent for the Period	17.00%
Finance lease, liability, payment, due			$ 3,723
Finance lease, liability, payments, remainder of fiscal year			784
Finance lease, liability, payments, due year two			1,470
Finance lease, liability, payments, due year three			1,470
Financing lease right-of-use assets		$ 75,687	3,593	$ 78,520
Finance lease, liability			$ 3,593

Stock-Based Compensation - Additional Information (Detail) - Restricted Stock Units (RSUs) $ in Thousands	3 Months Ended
	Mar. 31, 2020 USD ($) shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of restricted stock units, granted \| shares	49,800
Restricted stock units, aggregate grant date fair value \| $	$ 890
Stock plan vesting period	3 years 10 months 17 days
Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock plan vesting period	1 year
Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock plan vesting period	4 years

Stockholders' Deficit - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Schedule Of Stockholders Equity [Line Items]
Common stock, authorized shares reserved for future issuance	5,415,582
Common stock, shares authorized	50,000,000	50,000,000
Stock Repurchase Program
Schedule Of Stockholders Equity [Line Items]
Stock repurchase program, number of shares authorized to be repurchased	1,070,665
Stock repurchase program, authorized amount	$ 9,383
Common stock canceled and returned to pool of authorized shares	1,067,804
Stock repurchase program, remaining authorized repurchase amount	$ 10,617

Common Stock for Future Issuance (Detail)	Mar. 31, 2020 shares
Class Of Stock [Line Items]
Outstanding stock options	179,363
Restricted stock units	1,508,263
Total common shares reserved for future issuance	5,415,582
Stock Award Plans
Class Of Stock [Line Items]
Common stock available for future issuance	3,622,233
ESPP
Class Of Stock [Line Items]
Common stock available for future issuance	105,723

Summary of Disaggregation of Revenue by Service Line (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Disaggregation Of Revenue [Line Items]
Revenue	$ 66,154	$ 68,299
Subscription
Disaggregation Of Revenue [Line Items]
Revenue	45,990	47,869
Platform
Disaggregation Of Revenue [Line Items]
Revenue	6,005	5,143
Professional Services
Disaggregation Of Revenue [Line Items]
Revenue	14,159	15,287
Total Software Services
Disaggregation Of Revenue [Line Items]
Revenue	$ 51,995	$ 53,012

Summary of Contract Assets and Contract Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Revenue From Contract With Customer [Abstract]
Contract assets	$ 13,870	$ 16,685	$ 12,383	$ 12,798
Contract liabilities:
Deferred revenue	$ 34,539	$ 38,508	$ 46,895	$ 45,863

Revenue - Additional Information (Detail) - USD ($)	3 Months Ended
Revenue - Additional Information (Detail) - USD ($)	Mar. 31, 2020	Mar. 31, 2019
Revenue From Contract With Customer [Abstract]
Asset impairment charges related to contract assets	$ 0	$ 0
Changes in the contract assets outside of standard revenue and billing activity	0
Revenue recognized included in deferred revenue beginning balance	19,766,000
Favorable adjustments to revenue arising from performance obligations satisfied or partially satisfied in previous periods	660,000
Aggregate amount of unsatisfied or partially unsatisfied performance obligations	$ 190,000,000

Revenue - Additional Information (Detail1)	Mar. 31, 2020
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-04-01
Disaggregation Of Revenue [Line Items]
Performance obligations expected satisfaction period	3 years

Income Taxes - Additional Information (Detail)	3 Months Ended
Income Taxes - Additional Information (Detail)	Mar. 31, 2020
Maximum
Income Taxes [Line Items]
Effective federal tax rate	1.00%

Segments and Geographic Information - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2020 Segment
Segment Reporting [Abstract]
Number of Operating Segments	1

Related Parties - Additional Information (Detail)	3 Months Ended
Related Parties - Additional Information (Detail)	Mar. 31, 2020 USD ($) Lease_Agreements	Mar. 31, 2019 USD ($)	Dec. 31, 2019 USD ($)
Related Party Transaction [Line Items]
Lease operating expenses	$ 7,358,000	$ 3,331,000
Due to related party, current	209,000		$ 791,000
Stockholders and Executives
Related Party Transaction [Line Items]
Due to related party, current	0		0
Service from related party	120,000	119,000
Company Director
Related Party Transaction [Line Items]
Due to related party, current	26,000		$ 0
Service from related party	26,000	$ 35,000
Aggregate amount of payments	$ 115,000
Related Party Leasing Arrangements \| Non-Cancellable Leases
Related Party Transaction [Line Items]
Number of Lease agreements \| Lease_Agreements	3
Lease agreement period	15 years
Lease renewal option term	5 years
Extended leases, expiration date	Dec. 31, 2031
Percentage of fixed annual rent increases	3.00%

Subsequent Events - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended			3 Months Ended
	May 31, 2020	Apr. 30, 2020	Apr. 28, 2020	Mar. 31, 2020
Subsequent Event
Subsequent Event [Line Items]
Issuance of common stock upon exercises of stock option and vesting of restricted stock units	288,232	288,232
Common stock purchased		$ 35,508
Common stock, purchase price		$ 285
Subsequent Event \| COVID-19
Subsequent Event [Line Items]
Reduction in Workforce			17.00%
Capital Expenditure			$ 5,000
Minimum \| Subsequent Event \| Restructuring Charges \| COVID-19
Subsequent Event [Line Items]
Restructuring Charges			5,000
Maximum \| Subsequent Event \| Restructuring Charges \| COVID-19
Subsequent Event [Line Items]
Restructuring Charges			$ 7,000
Restricted Stock Units (RSUs)
Subsequent Event [Line Items]
Number of restricted stock units, granted				49,800
Restricted stock units, aggregate grant date fair value				$ 890
Stock plan vesting period				3 years 10 months 17 days
Restricted Stock Units (RSUs) \| Subsequent Event
Subsequent Event [Line Items]
Number of restricted stock units, granted	1,225,460
Restricted stock units, aggregate grant date fair value	$ 12,524
Stock plan vesting period	4 years
Weighted-average stock vesting period	3 years 1 month 2 days
Restricted Stock Units (RSUs) \| Minimum
Subsequent Event [Line Items]
Stock plan vesting period				1 year
Restricted Stock Units (RSUs) \| Maximum
Subsequent Event [Line Items]
Stock plan vesting period				4 years
Performance Based Restricted Stock Units R S Us \| Subsequent Event
Subsequent Event [Line Items]
Number of restricted stock units, granted	785,596
Restricted stock units, aggregate grant date fair value	$ 8,029
Restricted stock units, aggregate grant date fair value assuming target achievement	$ 6,206
Weighted-average stock vesting period	2 years 4 months 9 days
Performance Based Restricted Stock Units R S Us \| Minimum \| Subsequent Event
Subsequent Event [Line Items]
Stock plan vesting period	1 year
Shares issued vesting percentage	0.00%
Performance Based Restricted Stock Units R S Us \| Maximum \| Subsequent Event
Subsequent Event [Line Items]
Stock plan vesting period	3 years
Shares issued vesting percentage	100.00%